D
Grace Therapeutics, Inc. GRCE
$3.21 $0.103.12% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 37.83% 2.58%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -2.86% -14.12%
Operating Income 2.86% 14.12%
Income Before Tax -780.10% 91.97%
Income Tax Expenses -- -68.26%
Earnings from Continuing Operations -628.62% 115.31%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -628.62% 115.31%
EBIT 2.86% 14.12%
EBITDA 2.86% 14.13%
EPS Basic -558.91% 112.74%
Normalized Basic EPS -667.44% 93.35%
EPS Diluted -558.91% 112.74%
Normalized Diluted EPS -667.44% 93.35%
Average Basic Shares Outstanding 15.14% 20.20%
Average Diluted Shares Outstanding 15.14% 20.20%
Dividend Per Share -- --
Payout Ratio -- --